Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tradr 2X Short TSLA Daily ETF
TSLQ
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
AMRN Amarin
- 10.330
- +0.010+0.10%
Close Apr 29 16:00 ET
- 10.180
- -0.150-1.45%
Post 17:43 ET
213.93MMarket Cap-2.58P/E (TTM)
10.425High10.030Low63.50KVolume10.190Open10.320Pre Close648.81KTurnover0.34%Turnover RatioLossP/E (Static)20.71MShares20.60052wk High0.44P/B192.45MFloat Cap7.08052wk Low--Dividend TTM18.63MShs Float13500.000Historical High--Div YieldTTM3.83%Amplitude7.080Historical Low10.217Avg Price1Lot Size
About Amarin Company
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAMRN
Company NameAmarin
Listing DateApr 1, 1993
Issue Price6.00
Founded1989
CEOMr. Aaron D. Berg
MarketNASDAQ
Employees275
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressOne Central Plaza,36 Dame Street,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-6699-020
Websitehttp://www.amarincorp.com
Company Executives
- Name
- Position
- Salary
- Aaron D. Berg
- Director, President and Chief Executive Officer
- 3.28M
- Peter Fishman
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 606.00K
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 701.82K
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 1.73M
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 240.10K
- Michael Torok
- Director
- --
- Mark DiPaolo, Esq.
- Independent Director
- 224.51K
- Patrice Bonfiglio
- Independent Director
- 232.66K
- Diane E. Sullivan
- Independent Director
- 237.46K
- Oliver O'Connor
- Independent Director
- 208.18K
- Louis Sterling, III
- Independent Director
- 233.80K
- Keith L. Horn
- Independent Director
- 238.06K
- Dr. Paul Cohen, M.D.
- Independent Director
- 226.79K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now